Health Care, Pharmaceuticals, Biotech,
Civil Litigation
Jun. 29, 2021
Drug companies open defense with opioid advocate
Four opioid manufacturers are accused by four California communities of false advertising and creating a public nuisance by allegedly downplaying the risks of opioid addiction in their marketing.
Pharmaceutical companies accused of fueling the opioid crisis in California began their case in chief Monday in a $50 billion bench trial in Orange County.
Four opioid manufacturers including Allergan PLC, the maker of the morphine pill Kadian, are accused by four California communities of false advertising and creating a public nuisance by allegedly downplaying the risks of opioid addiction in their marketing.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care, Pharmaceuticals, Biotech, Civil Litigation
No evidence promotion increases opioid use, economist testifies
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Most opioid addicts had history of drug abuse, doctor testifies
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Former J&J medical consultant testifies in OC opioid trial
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
California joins opponents of $4.5B Purdue Pharma settlement
By Craig Anderson
Health Care, Pharmaceuticals, Biotech, Civil Litigation
No link between J&J opioids and sales in California, expert testifies
By Blaise Scemama
Civil Litigation
Dismissal motion denied, trial against opioid makers continues
By Blaise Scemama
Civil Litigation
State drops 2 opioid defendants, judge mulls total dismissal
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Judge gets several 1,000-page motions from opioid trial plaintiffs
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Opioid MDL against McKinsey heads to San Francisco
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech
4 pharma companies say state has not made its case in Orange County trial
By Blaise Scemama
